199 related articles for article (PubMed ID: 1293176)
1. Nosological considerations of the neurofibromatoses.
Viskochil D; Carey JC
J Dermatol; 1992 Nov; 19(11):873-80. PubMed ID: 1293176
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis. Nosological considerations.
Badiu C; Stefanache F
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatoses. Types, classification and diagnostic criteria].
Poptodorov G
Khirurgiia (Sofiia); 2001; 57(1-2):56-8. PubMed ID: 12024659
[TBL] [Abstract][Full Text] [Related]
4. The different forms of neurofibromatosis.
Ruggieri M
Childs Nerv Syst; 1999 Jul; 15(6-7):295-308. PubMed ID: 10461778
[TBL] [Abstract][Full Text] [Related]
5. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis-Practice Resource of the National Society of Genetic Counselors.
Radtke HB; Bergner AL; Goetsch AL; McGowan C; Panzer K; Cannon A
J Genet Couns; 2020 Oct; 29(5):692-714. PubMed ID: 32602153
[TBL] [Abstract][Full Text] [Related]
6. Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.
Bettegowda C; Upadhayaya M; Evans DG; Kim A; Mathios D; Hanemann CO;
Neurology; 2021 Aug; 97(7 Suppl 1):S91-S98. PubMed ID: 34230207
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
8. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostics of neurofibromatosis (Recklinghausen disease)].
Ardashev VN; Seriakov AP; Nikolaeva SN; Konev AV; Smolin AV
Voen Med Zh; 2004 Jun; 325(6):41-4. PubMed ID: 15327140
[No Abstract] [Full Text] [Related]
10. Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
Hanemann CO; Blakeley JO; Nunes FP; Robertson K; Stemmer-Rachamimov A; Mautner V; Kurtz A; Ferguson M; Widemann BC; Evans DG; Ferner R; Carroll SL; Korf B; Wolkenstein P; Knight P; Plotkin SR;
Neurology; 2016 Aug; 87(7 Suppl 1):S40-8. PubMed ID: 27527649
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Detection of
Bianchessi D; Ibba MC; Saletti V; Blasa S; Langella T; Paterra R; Cagnoli GA; Melloni G; Scuvera G; Natacci F; Cesaretti C; Finocchiaro G; Eoli M
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32575496
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
Blakeley JO; Plotkin SR
Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
[TBL] [Abstract][Full Text] [Related]
13. New insights into the neurofibromatoses.
Gutmann DH
Curr Opin Neurol; 1994 Apr; 7(2):166-71. PubMed ID: 8019663
[TBL] [Abstract][Full Text] [Related]
14. Multiple or familial café-au-lait spots is neurofibromatosis type 6: clarification of a diagnosis.
Madson JG
Dermatol Online J; 2012 May; 18(5):4. PubMed ID: 22630574
[TBL] [Abstract][Full Text] [Related]
15. The neurofibromatoses. An overview.
Ruggieri M; Huson SM
Ital J Neurol Sci; 1999 Apr; 20(2):89-108. PubMed ID: 10933430
[TBL] [Abstract][Full Text] [Related]
16. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
[TBL] [Abstract][Full Text] [Related]
17. [Neurofibromatoses].
Zimmer A
Radiologe; 2013 Dec; 53(12):1077-83. PubMed ID: 24258315
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular characterization of neurofibromatosis in southern Brazil.
Rosset C; Vairo F; Cristina Bandeira I; Fonini M; Netto CBO; Ashton-Prolla P
Expert Rev Mol Diagn; 2018 Jun; 18(6):577-586. PubMed ID: 29685074
[TBL] [Abstract][Full Text] [Related]
19. Optimizing biologically targeted clinical trials for neurofibromatosis.
Gutmann DH; Blakeley JO; Korf BR; Packer RJ
Expert Opin Investig Drugs; 2013 Apr; 22(4):443-62. PubMed ID: 23425047
[TBL] [Abstract][Full Text] [Related]
20. [Importance of multidisciplinary consultations for children with neurofibromatosis].
Bursztyn J; Rodriguez D
J Fr Ophtalmol; 1999 Nov; 22(9):959-62. PubMed ID: 10609170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]